Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London
PR Newswire•10/11/2026•16:05 ET
0
Key Highlights
- ➤Nuvation Bio will participate in a Jefferies Global Healthcare Conference fireside chat November 17.
- ➤David Hung and Philippe Sauvage will represent Nuvation Bio at the London conference.
- ➤Nuvation Bio’s pipeline includes taletrectinib, safusidenib, and a drug-drug conjugate program.
Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London PR Newswire
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 2:30 p.m. GMT.
Get started
Create a free account to read the full story.